Literature DB >> 24478370

Tissue plasminogen activator contributes to alterations of neuronal migration and activity-dependent responses in fragile X mice.

V Swaroop Achuta1, Veronika Rezov, Marko Uutela, Verna Louhivuori, Lauri Louhivuori, Maija L Castrén.   

Abstract

Fragile X syndrome (FXS) is the most common inherited neurodevelopmental disorder with intellectual disability. Here, we show that the expression of tissue plasminogen activator (tPA) is increased in glial cells differentiated from neural progenitors of Fmr1 knock-out mice, a mouse model for FXS, and that tPA is involved in the altered migration and differentiation of these progenitors lacking FMR1 protein (FMRP). When tPA function is blocked with an antibody, enhanced migration of doublecortin-immunoreactive neurons in 1 d differentiated FMRP-deficient neurospheres is normalized. In time-lapse imaging, blocking the tPA function promotes early glial differentiation and reduces the velocity of nuclear movement of FMRP-deficient radial glia. In addition, we show that enhanced intracellular Ca(2+) responses to depolarization with potassium are prevented by the treatment with the tPA-neutralizing antibody in FMRP-deficient cells during early neural progenitor differentiation. Alterations of the tPA expression in the embryonic, postnatal, and adult brain of Fmr1 knock-out mice suggest an important role for tPA in the abnormal neuronal differentiation and plasticity in FXS. Altogether, the results indicate that tPA may prove to be an interesting potential target for pharmacological intervention in FXS.

Entities:  

Keywords:  FMRP; depolarization; differentiation; glia; neurons; stem cells

Mesh:

Substances:

Year:  2014        PMID: 24478370      PMCID: PMC6827590          DOI: 10.1523/JNEUROSCI.3753-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Regulation of neurogenesis by interkinetic nuclear migration through an apical-basal notch gradient.

Authors:  Filippo Del Bene; Ann M Wehman; Brian A Link; Herwig Baier
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

2.  Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals.

Authors:  Frédéric Cassé; Isabelle Bardou; Lydia Danglot; Aurélien Briens; Axel Montagne; Jérôme Parcq; Anuradha Alahari; Thierry Galli; Denis Vivien; Fabian Docagne
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 3.  Tissue plasminogen activator as a key effector in neurobiology and neuropathology.

Authors:  T Teesalu; A Kulla; T Asser; M Koskiniemi; A Vaheri
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

Review 4.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors:  Gül Dölen; Mark F Bear
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

5.  Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome.

Authors:  Laura K K Pacey; Laurie C Doering
Journal:  Glia       Date:  2007-11-15       Impact factor: 7.452

6.  Neurotransmitter responsiveness during early maturation of neural progenitor cells.

Authors:  Virve Kärkkäinen; Verna Louhivuori; Maija L Castrén; Karl E Akerman
Journal:  Differentiation       Date:  2008-11-18       Impact factor: 3.880

7.  Brain-derived neurotrophic factor increases the motility of a particular N-methyl-D-aspartate /GABA-responsive subset of neural progenitor cells.

Authors:  L C Jansson; L Louhivuori; H-K Wigren; T Nordström; V Louhivuori; M L Castrén; K E Åkerman
Journal:  Neuroscience       Date:  2012-08-23       Impact factor: 3.590

8.  Localization of tissue plasminogen activator mRNA in adult rat brain.

Authors:  J H Ware; A J Dibenedetto; R N Pittman
Journal:  Brain Res Bull       Date:  1995       Impact factor: 4.077

9.  FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

Authors:  Jennifer C Darnell; Sarah J Van Driesche; Chaolin Zhang; Ka Ying Sharon Hung; Aldo Mele; Claire E Fraser; Elizabeth F Stone; Cynthia Chen; John J Fak; Sung Wook Chi; Donny D Licatalosi; Joel D Richter; Robert B Darnell
Journal:  Cell       Date:  2011-07-22       Impact factor: 41.582

Review 10.  Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders.

Authors:  Takeshi Kawauchi; Mima Shikanai; Yoichi Kosodo
Journal:  Genes Cells       Date:  2013-01-07       Impact factor: 1.891

View more
  8 in total

1.  Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain.

Authors:  Marianne Petro; Hayder Jaffer; Jun Yang; Shushi Kabu; Viola B Morris; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

2.  ELAVL2-regulated transcriptional and splicing networks in human neurons link neurodevelopment and autism.

Authors:  Stefano Berto; Noriyoshi Usui; Genevieve Konopka; Brent L Fogel
Journal:  Hum Mol Genet       Date:  2016-06-03       Impact factor: 6.150

3.  Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease.

Authors:  Lipsa Das; Michael A Banki; Pardis Azmoon; Donald Pizzo; Steven L Gonias
Journal:  Am J Pathol       Date:  2021-01-17       Impact factor: 4.307

4.  Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination.

Authors:  Camille Leonetti; Richard Macrez; Mathilde Pruvost; Yannick Hommet; Jérémie Bronsard; Antoine Fournier; Maxime Perrigault; Isabel Machin; Denis Vivien; Diego Clemente; Fernando De Castro; Eric Maubert; Fabian Docagne
Journal:  Mol Neurodegener       Date:  2017-02-23       Impact factor: 14.195

5.  Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder.

Authors:  Ekaterina Savchenko; Yajuvinder Singh; Henna Konttinen; Katarina Lejavova; Laura Mediavilla Santos; Alexandra Grubman; Virve Kärkkäinen; Velta Keksa-Goldsteine; Nikolay Naumenko; Pasi Tavi; Anthony R White; Tarja Malm; Jari Koistinaho; Katja M Kanninen
Journal:  Dis Model Mech       Date:  2017-07-21       Impact factor: 5.758

6.  Increased Calcium Influx through L-type Calcium Channels in Human and Mouse Neural Progenitors Lacking Fragile X Mental Retardation Protein.

Authors:  Claudia Danesi; Venkat Swaroop Achuta; Padraic Corcoran; Ulla-Kaisa Peteri; Giorgio Turconi; Nobuaki Matsui; Ilyas Albayrak; Veronika Rezov; Anders Isaksson; Maija L Castrén
Journal:  Stem Cell Reports       Date:  2018-11-29       Impact factor: 7.765

7.  Altered cortical Cytoarchitecture in the Fmr1 knockout mouse.

Authors:  Frankie H F Lee; Terence K Y Lai; Ping Su; Fang Liu
Journal:  Mol Brain       Date:  2019-06-14       Impact factor: 4.041

8.  A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system.

Authors:  Julia F Alterman; Bruno M D C Godinho; Matthew R Hassler; Chantal M Ferguson; Dimas Echeverria; Ellen Sapp; Reka A Haraszti; Andrew H Coles; Faith Conroy; Rachael Miller; Loic Roux; Paul Yan; Emily G Knox; Anton A Turanov; Robert M King; Gwladys Gernoux; Christian Mueller; Heather L Gray-Edwards; Richard P Moser; Nina C Bishop; Samer M Jaber; Matthew J Gounis; Miguel Sena-Esteves; Athma A Pai; Marian DiFiglia; Neil Aronin; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2019-08-02       Impact factor: 54.908

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.